New Zealand - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, New Zealand Hospital Average Length of Stay for Malignant Neoplasm of Prostate increased 2.2% year on year. In 2019, the country was ranked number 2 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate with 11.6 Days. South Korea lead the ranking with 15.9 Days in 2019, that is stable compared to 2018. New Zealand recorded the best 5 years average growth at +2.2% per year, while Mexico was the worst growing country at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 11.60 |
| 2018 | 11.70 |
| 2017 | 11.00 |
| 2016 | 14.10 |
| 2015 | 12.60 |
Download all data from 1975 to 2019
How does New Zealand rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data |
| 3 |
#3
Lithuania
|
10.80 | 2019 | -1.8 % | -1.6 % | View data |
| 4 |
#4
Germany
|
10.50 | 2019 | -0.9 % | -1.3 % | View data |
| 4 |
#4
Slovakia
|
10.50 | 2019 | -0.9 % | +0.2 % | View data |